NEW YORK, Oct. 25, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of PennyMac Mortgage Investment Trust PMT, Amicus Therapeutics, Inc. FOLD, Children's Place, Inc. PLCE, PLDT Inc. PHI, NanoString Technologies, Inc. NSTG, and Worthington Industries, Inc. WOR, including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
PMT DOWNLOAD: http://MarketSourceResearch.com/register/?so=PMT
FOLD DOWNLOAD: http://MarketSourceResearch.com/register/?so=FOLD
PLCE DOWNLOAD: http://MarketSourceResearch.com/register/?so=PLCE
PHI DOWNLOAD: http://MarketSourceResearch.com/register/?so=PHI
NSTG DOWNLOAD: http://MarketSourceResearch.com/register/?so=NSTG
WOR DOWNLOAD: http://MarketSourceResearch.com/register/?so=WOR
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Market Source Research, available for free download at the links above, examine PennyMac Mortgage Investment Trust PMT, Amicus Therapeutics, Inc. FOLD, Children's Place, Inc. PLCE, PLDT Inc. PHI, NanoString Technologies, Inc. NSTG, and Worthington Industries, Inc. WOR on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed October 23rd, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
PENNYMAC MORTGAGE INVESTMENT TRUST (PMT) REPORT OVERVIEW
PennyMac Mortgage Investment Trust's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, PennyMac Mortgage Investment Trust reported revenue of $123.06MM vs $122.39MM (up 0.55%) and analysts estimated basic earnings per share $0.49 vs $0.39 (up 25.64%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, PennyMac Mortgage Investment Trust reported revenue of $469.31MM vs $421.86MM (up 11.25%) and analysts estimated basic earnings per share $1.53 vs $1.09 (up 40.37%). Analysts expect earnings to be released on November 1st, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.20. The estimated EPS forecast for the next fiscal year is $1.75 and is expected to report on February 14th, 2019.
To read the full PennyMac Mortgage Investment Trust (PMT) report, download it here: http://MarketSourceResearch.com/register/?so=PMT
-----------------------------------------
AMICUS THERAPEUTICS, INC. (FOLD) REPORT OVERVIEW
Amicus Therapeutics' Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Amicus Therapeutics reported revenue of $21.31MM vs $7.16MM (up 197.69%) and analysts estimated basic earnings per share -$0.33 vs -$0.34. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Amicus Therapeutics reported revenue of $36.93MM vs $4.96MM (up 644.86%) and analysts estimated basic earnings per share -$1.85 vs -$1.49. Analysts expect earnings to be released on November 14th, 2018. The report will be for the fiscal period ending September 30th, 2018. Reported EPS for the same quarter last year was -$0.41. The estimated EPS forecast for the next fiscal year is -$0.75 and is expected to report on February 27th, 2019.
To read the full Amicus Therapeutics, Inc. (FOLD) report, download it here: http://MarketSourceResearch.com/register/?so=FOLD
-----------------------------------------
CHILDREN'S PLACE, INC. (PLCE) REPORT OVERVIEW
Children's Place's Recent Financial Performance
For the three months ended July 31st, 2018 vs July 31st, 2017, Children's Place reported revenue of $448.72MM vs $373.60MM (up 20.11%) and analysts estimated basic earnings per share $0.45 vs $0.81 (down 44.44%). For the twelve months ended January 31st, 2018 vs January 31st, 2017, Children's Place reported revenue of $1,870.28MM vs $1,785.32MM (up 4.76%) and analysts estimated basic earnings per share $4.82 vs $5.51 (down 12.52%). Analysts expect earnings to be released on November 21st, 2018. The report will be for the fiscal period ending October 31st, 2018. Reported EPS for the same quarter last year was $2.58. The estimated EPS forecast for the next fiscal year is $9.43 and is expected to report on March 19th, 2019.
To read the full Children's Place, Inc. (PLCE) report, download it here: http://MarketSourceResearch.com/register/?so=PLCE
-----------------------------------------
PLDT INC. (PHI) REPORT OVERVIEW
PLDT's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, PLDT reported revenue of $797.08MM vs $800.52MM (down 0.43%) and basic earnings per share $0.43 vs $1.08 (down 60.13%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, PLDT reported revenue of $3,166.54MM vs $3,487.03MM (down 9.19%) and analysts estimated basic earnings per share $1.22 vs $1.95 (down 37.38%). Analysts expect earnings to be released on November 8th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.53. The estimated EPS forecast for the next fiscal year is $2.23 and is expected to report on March 14th, 2019.
To read the full PLDT Inc. (PHI) report, download it here: http://MarketSourceResearch.com/register/?so=PHI
-----------------------------------------
NANOSTRING TECHNOLOGIES, INC. (NSTG) REPORT OVERVIEW
NanoString Technologies' Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, NanoString Technologies reported revenue of $25.00MM vs $34.59MM (down 27.73%) and analysts estimated basic earnings per share -$0.80 vs -$0.20. For the twelve months ended December 31st, 2017 vs December 31st, 2016, NanoString Technologies reported revenue of $114.91MM vs $86.49MM (up 32.86%) and analysts estimated basic earnings per share -$1.84 vs -$2.34. Analysts expect earnings to be released on November 8th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.45. The estimated EPS forecast for the next fiscal year is -$2.10 and is expected to report on March 6th, 2019.
To read the full NanoString Technologies, Inc. (NSTG) report, download it here: http://MarketSourceResearch.com/register/?so=NSTG
-----------------------------------------
WORTHINGTON INDUSTRIES, INC. (WOR) REPORT OVERVIEW
Worthington Industries' Recent Financial Performance
For the three months ended August 31st, 2018 vs August 31st, 2017, Worthington Industries reported revenue of $988.11MM vs $848.24MM (up 16.49%) and analysts estimated basic earnings per share $0.94 vs $0.73 (up 28.77%). For the twelve months ended May 31st, 2018 vs May 31st, 2017, Worthington Industries reported revenue of $3,581.62MM vs $3,014.11MM (up 18.83%) and analysts estimated basic earnings per share $3.20 vs $3.28 (down 2.44%). Analysts expect earnings to be released on December 18th, 2018. The report will be for the fiscal period ending November 30th, 2018. The reported EPS for the same quarter last year was $0.65. The estimated EPS forecast for the next fiscal year is $3.34 and is expected to report on June 26th, 2019.
To read the full Worthington Industries, Inc. (WOR) report, download it here: http://MarketSourceResearch.com/register/?so=WOR
-----------------------------------------
ABOUT MARKET SOURCE RESEARCH
Market Source Research delivers the key research reports that helps serious investors, registered brokers, professional traders, and personal investment advisers find reliable information in today's markets. Market Source Research's team is comprised of financial professionals, many of which hold Chartered Financial Analyst® (CFA®) designations and FINRA® BrokerCheck® certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source Research is dedicated to providing accurate, informative, and objective content that's ahead of the curve. With insights on individual companies as well as sectors, readers get the industry's best available combination of big-picture perspective as well as granular detail.
REGISTERED MEMBER STATUS
Market Source Research's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Market Source Research's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Market Source Research's Compliance department by Phone, at +1 (704) 343-6361, or by E-mail at compliance@MarketSourceResearch.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Market Source Research, Market Source Research members, and/or Market Source Research affiliates are not responsible for any gains or losses that result from the opinions expressed. Market Source Research makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Market Source Research has not been compensated for the publication of this press release by any of the above mentioned companies. Market Source Research is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Hugo Moreau, Media Department
Office: +1 (704) 343-6361
E-mail: media@MarketSourceResearch.com
© 2018 Market Source Research. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@MarketSourceResearch.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
